Acute exercise protects against doxorubicin cardiotoxicity

Integrative Cancer Therapies

Volumn 7, Issue 3, 2008, Pages 147-154

  Wonders, Karen Y ^a   Hydock, David S ^b   Schneider, Carole M ^b   Hayward, Reid ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTHERN COLORADO   (United States)

Author keywords

Cancer; Cardiac function; Chemotherapy; Physical activity; Preconditioning

Indexed keywords

DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART PROTECTION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOXORUBICIN; HEART DISEASES; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 52649143297     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735408322848     Document Type: Article

References (49)

1. Monti E., Prosperi E., Supino R., Bottiroli G. Free radical-dependent DNA lesions are involved in the delayed cardiotoxicity induced by adriamycin in the rat. Anticancer Res. 1995 ; 15: 193-197.
2. Nousiainen T., Jantunen E., Vanninen E., Hartikainen J. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. Br J Cancer. 2002 ; 86: 1697-1700.
3. Ascensao AA, Magalhaes J., Soares JM, et al. Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis. Am J Physiol Heart Circ Physiol. 2005 ; 289: H722 - H731.
4. Jang YM, Kendaiah S., Drew B., et al. Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats. FEBS Lett. 2004 ; 577: 483-490.
5. Teraoka K., Hirano M., Yamaguchi K., Yamashina A. Progressive cardiac dysfunction in adriamycin-induced cardiomyopathy rats. Eur J Heart Fail. 2000 ; 2: 373-378.
6. Berrak SG, Ewer MS, Jaffe N., et al. Doxorubicin cardiotoxicity in children: reduced incidence of cardiac dysfunction associated with continuous-infusion schedules. Oncol Rep. 2001 ; 8: 611-614.
7. Legha SS, Benjamin RS, Mackay B., et al. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med. 1982 ; 96: 133-139.
8. Legha SS, Benjamin RS, Mackay B., et al. Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancer. Cancer. 1982 ; 49: 1762-1766.
9. Li T., Danelisen I., Bello-Klein A., Singal PK Effects of probucol on changes of antioxidant enzymes in adriamycin- induced cardiomyopathy in rats. Cardiovasc Res. 2000 ; 46: 523-530.
10. Siveski-Iliskovic N., Hill M., Chow DA, Singal PK Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation. 1995 ; 91: 10-15.
11. Katsuhisa S., Takahashi M., Kitano M., Sugimura T., Wakabayash K. Suppression of azoxymethane-induced colonic premalignant lesion formation by coenzyme Q10 in rats. Asian Pacific J Cancer Prev. 2006 ; 7: 599-603.
12. Nowak D., Pierscinski G., Drzewoski J. Ambroxol inhibits doxorubicin-induced lipid peroxidation in heart of mice. Free Radic Biol Med. 1995 ; 19: 659-663.
13. Al-Majed AA, Gdo AM, Al-Shabanah OA, Mansour MA Alphalipoic acid ameliorates myocardial toxicity induced by doxorubicin. Pharmacol Res. 2002 ; 46: 499-503.
14. Abdel-Wahab MH, El-Mahdy MA, Abd-Ellah MF, Helal GK, Khalifa F., Hamada FM Influence of P-coumaric acid on doxorubicin-induced oxidative stress in rat's heart. Pharmacol Res. 2003 ; 48: 461-465.
15. Dziegiel P., Murawska-Cialowicz E., Jethon Z., et al. Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication. J Pineal Res. 2003 ; 35: 183-187.
16. Cusack BJ, Gambliel H., Musser B., et al. Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism. Cancer Chemother Pharmacol. 2006 ; 58: 517-526.
17. Saad SY, Najjar TA, Al-Rikabi AC The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res. 2001 ; 43: 211-218.
18. Mrozek E., Rhoades CA, Allen J., Hade EM, Shapiro CL Phase I trial of liposomal encapsulated doxorubicin (Myocet; D-99) and weekly docetaxel in advanced breast cancer patients. Ann Oncol. 2005 ; 16: 1087-1093.
19. Taylor RP, Harris MB, Starnes JW Acute exercise can improve cardioprotection without increasing heat shock protein content. Am J Physiol. 1999 ; 276: H1098 - H1102.
20. Taylor RP, Olsen ME, Starnes JW Improved postischemic function following acute exercise is not mediated by nitric oxide synthase in the rat heart. Am J Physiol Heart Circ Physiol. 2007 ; 292: H601 - H607.
21. Ascensao A., Magalhaes J., Soares J., et al. Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. Int J Cardiol. 2005 ; 100: 451-460.
22. Chicco AJ, Schneider CM, Hayward R. Exercise training attenuates acute doxorubicin-induced cardiac dysfunction. J Cardiovasc Pharmacol. 2006 ; 47: 182-189.
23. Chicco AJ, Schneider CM, Hayward R. Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart. Am J Physiol Regul Integr Comp Physiol. 2005 ; 289: R424 - R431.
24. Kanter MM, Hamlin RL, Unverferth DV, Davis HW, Merola AJ Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin. J Appl Physiol. 1985 ; 59: 1298-1303.
25. Ji LL, Mitchell EW Effects of adriamycin on heart mitochondrial function in rested and exercised rats. Biochem Pharmacol. 1994 ; 47: 877-885.
26. Combs AB, Hudman SL, Bonner HW Effect of exercise stress upon the acute toxicity of adriamycin in mice. Res Commun Chem Pathol Pharmacol. 1979 ; 23: 395-398.
27. Leeuwenburgh C., Leichtweis S., Hollander J., Fiebig R., Gore M., Ji LL Effect of acute exercise on glutathione deficient heart. Mol Cell Biochem. 1996 ; 156: 17-24.
28. Venditti P., Di Meo S. Antioxidants, tissue damage, and endurance in trained and untrained young male rats. Arch Biochem Biophys. 1996 ; 331: 63-68.
29. Aydin C., Ince E., Koparan S., Cangul IT, Naziroglu M., Ak F. Protective effects of long term dietary restriction on swimming exercise-induced oxidative stress in the liver, heart and kidney of rat. Cell Biochem Funct. 2007 ; 25: 129-137.
30. Wonders KY, Hydock DS, Hayward R. Time course of changes in cardiac function during recovery after acute exercise. Appl Physiol Nutr Metab. 2007 ; 32: 1164-1169.
31. Kim C., Nam SW, Choi DY, et al. A new antithrombotic agent, aspalatone, attenuated cardiotoxicity induced by doxorubicin in the mouse: possible involvement of antioxidant mechanism. Life Sci. 1997 ; 60: L75 - L82.
32. Sun X., Zhou Z., Kang YJ Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart. Cancer Res. 2001 ; 61: 3382-3387.
33. Kang YJ, Chen Y., Epstein PN Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J Biol Chem. 1996 ; 271: 12610-12616.
34. Ji LL Antioxidant enzyme response to exercise and aging. Med Sci Sports Exerc. 1993 ; 25: 225-231.
35. Leeuwenburgh C., Hollander J., Leichtweis S., Griffiths M., Gore M., Ji LL Adaptations of glutathione antioxidant system to endurance training are tissue and muscle fiber specific. Am J Physiol. 1997 ; 272: R363 - R369.
36. Hong H., Johnson P. Antioxidant enzyme activities and lipid peroxidation levels in exercised and hypertensive rat tissues. Int J Biochem Cell Biol. 1995 ; 27: 923-931.
37. Kihlstrom M., Ojala J., Salminen A. Decreased level of cardiac antioxidants in endurance-trained rats. Acta Physiol Scand. 1989 ; 135: 549-554.
38. Brown DA, Jew KN, Sparagna GC, Musch TI, Moore RL Exercise training preserves coronary flow and reduces infarct size following ischemia-reperfusion in rat heart. J Appl Physiol. 2003 ; 95: 2510-2518.
39. Husain K. Interaction of physical training and chronic nitroglycerin treatment on blood pressure, nitric oxide, and oxidants/ antioxidants in the rat heart. Pharmacol Res. 2003 ; 48: 253-261.
40. Husain K., Somani SM, Boley TM, Hazelrigg SR Interaction of physical training and chronic nitroglycerin treatment on blood pressure and plasma oxidant/antioxidant systems in rats. Mol Cell Biochem. 2003 ; 247: 37-44.
41. Powers SK, Criswell D., Lawler J., et al. Rigorous exercise training increases superoxide dismutase activity in ventricular myocardium. Am J Physiol. 1993 ; 265: H2094 - H2098.
42. Powers SK, Demirel HA, Vincent HK, et al. Exercise training improves myocardial tolerance to in vivo ischemia-reperfusion in the rat. Am J Physiol. 1998 ; 275: R1468 - R1477.
43. Taylor RP, Ciccolo JT, Starnes JW Effect of exercise training on the ability of the rat heart to tolerate hydrogen peroxide. Cardiovasc Res. 2003 ; 58: 575-581.
44. Demirel HA, Powers SK, Zergeroglu MA, et al. Short-term exercise improves myocardial tolerance to in vivo ischemia-reperfusion in the rat. J Appl Physiol. 2001 ; 91: 2205-2212.
45. Hamilton KL, Staib JL, Phillips T., Hess A., Lennon SL, Powers SK Exercise, antioxidants, and HSP72: protection against myocardial ischemia/reperfusion. Free Radic Biol Med. 2003 ; 34: 800-809.
46. Locke M., Tanguay RM, Klabunde RE, Ianuzzo CD Enhanced postischemic myocardial recovery following exercise induction of HSP 72. Am J Physiol. 1995 ; 269: H320 - H325.
47. Babai L., Szigeti Z., Parratt JA, Vegh A. Delayed cardioprotective effects of exercise in dogs are aminoguanidine sensitive: possible involvement of nitric oxide. Clin Sci (Lond). 2002 ; 102: 435-445.
48. Yamashita N., Hoshida S., Otsu K., Asahi M., Kuzuya T., Hori M. Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J Exp Med. 1999 ; 189: 1699-1706.
49. Hamilton KL, Powers SK, Sugiura T., et al. Short-term exercise training can improve myocardial tolerance to I/R without elevation in heat shock proteins. Am J Physiol Heart Circ Physiol. 2001 ; 281: H1346 - H1352.